Rapid Saliva COVID-19 LambraTech Test
The revolutionary Israeli technology device for the Lambra company will be tested for the first time in the Community of Castilla la Mancha these days, a technology that allows the discovery of the COVID-19 virus between 1 and 2 seconds in saliva or nasopharyngeal sample.
This is a product classified as "In Vitro Diagnosis", it is not a "Self Diagnosis" product, therefore it cannot be sold to private persons, but to Hospitals, Health Centers, Clinics, Laboratories, Nursing Homes, Public Services , Mutuals for Risk Prevention or Companies, provided they have health personnel to carry them out.
The tests must be used following the criteria indicated by current legislation (RD 1162/2000 on medical devices for "in vitro" diagnosis).
In the purchase process, the number of the Registered Physician who will carry out the diagnosis and follow-up will be requested.